Pfizer’s COVID Vaccine Gets Full Approval From The FDA

This is the first COVID-19 vaccine to be subject to a complete evaluation by the U.S. regulator and to get an approval that puts the vaccine on par with other marketed vaccines. “While this and other vaccines have met the FDAs extensive, scientific requirements for emergency use permission, as the first FDA-approved COVID-19 vaccine, the public can be extremely confident that this vaccine meets the high standards for security, effectiveness, and manufacturing quality the FDA requires of an approved product,” acting FDA Commissioner Janet Woodcock stated in a declaration.

A June survey from the Kaiser Family Foundation found that 31% of unvaccinated individuals said they would be most likely to get a COVID-19 vaccine as soon as one receives full approval from the FDA. “While millions of individuals have currently securely gotten COVID-19 vaccines, we acknowledge that for some, the FDA approval of a vaccine may now impart extra self-confidence to get vaccinated,” Woodcock said. “Todays milestone puts us one action more detailed to altering the course of this pandemic in the U.S.”

The FDAs full approval uses to people 16 and older. Those between ages 12 and 15 can still receive the vaccine under the existing emergency situation usage permission. The FDA acted Monday without assembling a popular public conference of expert advisers to veterinarian details about the vaccine and make recommendations to the regulator. As of Sunday, 73% of grownups have had at least one dosage of the Pfizer, Moderna or Johnson & & Johnson vaccine. Pfizers vaccine is most typically administered, representing about 56% of the doses administered overall, according to information from the Centers for Disease Control and Prevention. Modernas COVID-19 vaccine stays under the FDAs review, however its approval is anticipated to follow in the future.

A nurse is handed a dosage of the Pfizer COVID-19 vaccine prior to administering it to an university student throughout a mobile vaccination center at California State University, Long Beach on Aug. 11.

toggle caption

Patrick T. Fallon/AFP through Getty Images

A nurse is handed a dose of the Pfizer COVID-19 vaccine prior to administering it to an university student during a mobile vaccination clinic at California State University, Long Beach on Aug. 11.

hide caption

Patrick T. Fallon/AFP via Getty Images

Patrick T. Fallon/AFP through Getty Images

A June survey from the Kaiser Family Foundation discovered that 31% of unvaccinated people stated they would be more most likely to get a COVID-19 vaccine as soon as one gets full approval from the FDA. “While millions of people have actually already securely received COVID-19 vaccines, we acknowledge that for some, the FDA approval of a vaccine might now instill additional confidence to get immunized,” Woodcock stated.

This is the first COVID-19 vaccine to be subject to a full evaluation by the U.S. regulator and to get an approval that puts the vaccine on par with other marketed vaccines. “While this and other vaccines have satisfied the FDAs rigorous, scientific requirements for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very positive that this vaccine fulfills the high requirements for security, efficiency, and manufacturing quality the FDA requires of an approved item,” acting FDA Commissioner Janet Woodcock stated in a statement.

Leave a Reply

Your email address will not be published. Required fields are marked *